search
Back to results

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

Primary Purpose

Androgenetic Alopecia

Status
Completed
Phase
Phase 3
Locations
Indonesia
Study Type
Interventional
Intervention
Minoxidil 5% Topical Solution
microneedling
Sponsored by
Indonesia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Androgenetic Alopecia

Eligibility Criteria

18 Years - 59 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria: Male Indonesian Age 18-59 years Diagnosis of androgenetic alopecia Hamilton-Norwood type III-IV Exclusion Criteria: Use of minoxidil or finasteride topical 1 month prior Use of minoxidil or finasteride oral 1 month prior Skin infection in the treatment area Cosmetic procedures for the treatment of alopecia androgenetic such as platelet rich plasma, laser therapy,or microneedling 3 months prior History of keloid

Sites / Locations

  • Cipto Mangungkusumo Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Minoxidil 5% solution

Combination therapy of microneedling and minoxidil 5% solution

Arm Description

Patients will receive minoxidil 5%, twice a day, for a total duration of 12 weeks.

Patients will receive a combination therapy of microneedling and minoxidil 5%. Minoxidil 5%, will be given twice a day for a total duration of 12 weeks. The microneedling treatment will be given every 4 weeks (week 0, week 4, week 8)for a total duration of 12 weeks.

Outcomes

Primary Outcome Measures

Density of hair
Increase density of hair in alopecia androgenetic patient
Diameter of hair
Increase diameter of hair in alopecia androgenetic patient

Secondary Outcome Measures

Full Information

First Posted
August 3, 2023
Last Updated
September 27, 2023
Sponsor
Indonesia University
search

1. Study Identification

Unique Protocol Identification Number
NCT05989165
Brief Title
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
Official Title
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
June 1, 2023 (Actual)
Primary Completion Date
September 1, 2023 (Actual)
Study Completion Date
September 15, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indonesia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare the effectiveness of combination therapy of microneedling and minoxidil in androgenetic alopecia of Indonesian men. The main questions it aims to answer are: Is there an increase in hair density with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? Is there an increase in hair diameter with combination therapy of microneedling and minoxidil versus minoxidil monotherapy? Participants will be divided into 2 groups. The first one will receive minoxidil monotherapy, and the second one will receive a combination therapy of microneedling and minoxidil. Researchers will compare those 2 groups to see if there is a difference of effectiveness based on hair density and diameter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Androgenetic Alopecia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Minoxidil 5% solution
Arm Type
Experimental
Arm Description
Patients will receive minoxidil 5%, twice a day, for a total duration of 12 weeks.
Arm Title
Combination therapy of microneedling and minoxidil 5% solution
Arm Type
Experimental
Arm Description
Patients will receive a combination therapy of microneedling and minoxidil 5%. Minoxidil 5%, will be given twice a day for a total duration of 12 weeks. The microneedling treatment will be given every 4 weeks (week 0, week 4, week 8)for a total duration of 12 weeks.
Intervention Type
Drug
Intervention Name(s)
Minoxidil 5% Topical Solution
Intervention Description
Patient will be given minoxidil 5% topical solution, twice a day for 12 weeks
Intervention Type
Device
Intervention Name(s)
microneedling
Intervention Description
Patient will be given microneedling treatment every 4 weeks
Primary Outcome Measure Information:
Title
Density of hair
Description
Increase density of hair in alopecia androgenetic patient
Time Frame
12 weeks
Title
Diameter of hair
Description
Increase diameter of hair in alopecia androgenetic patient
Time Frame
12 weeks

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male Indonesian Age 18-59 years Diagnosis of androgenetic alopecia Hamilton-Norwood type III-IV Exclusion Criteria: Use of minoxidil or finasteride topical 1 month prior Use of minoxidil or finasteride oral 1 month prior Skin infection in the treatment area Cosmetic procedures for the treatment of alopecia androgenetic such as platelet rich plasma, laser therapy,or microneedling 3 months prior History of keloid
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kara Adistri, MD
Organizational Affiliation
Faculty of medicine, University of Indonesia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cipto Mangungkusumo Hospital
City
Jakarta
State/Province
DKI Jakarta
ZIP/Postal Code
10430
Country
Indonesia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23960389
Citation
Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013 Jan;5(1):6-11. doi: 10.4103/0974-7753.114700.
Results Reference
result
PubMed Identifier
30886475
Citation
Kumar MK, Inamadar AC, Palit A. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia. J Cutan Aesthet Surg. 2018 Oct-Dec;11(4):211-216. doi: 10.4103/JCAS.JCAS_130_17.
Results Reference
result

Learn more about this trial

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

We'll reach out to this number within 24 hrs